RIGENERAND 产品代理

Founded as spin-off of the University of Modena and Reggio Emilia, Rigenerand is a joint venture between RanD, a biomedical company producing bioreactors for liver support and chemo-hyperthermic technology for cancer and researchers of the University of Modena e Reggio Emilia with a lasting expertise in cell and gene therapy. Thanks to the investment by the Principia III-Health SGR Fund and other local investors, Rigenerand is a first-class building of more than 1200 m2 including offices, R&D and quality control laboratories and a cell factory of 450 m2 with class-B and BL3 suites for cell and gene therapies manufacturing.